MAZE
Maze Therapeutics, Inc. · Healthcare
President, R&D & CMO Harold Bernstein sold $393K of Maze Therapeutics, Inc.
Sold$393,354
$26.22Price
15,000Shares
−100%Stake
What MAZE did after the filing
- The stock from Tue, May 19 open, $24.29
- +28.7%
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Jul 2 close.
Traded Thu, May 14. Filed Mon, May 18, 5:03 PM ET, after the close. Returns use the May 19 open and the Jul 2 close. Not investment advice.